dc.contributor.author | Moe, Fredrik Dreyer | |
dc.contributor.author | Berg, Henrik | |
dc.date.accessioned | 2023-04-11T12:37:58Z | |
dc.date.available | 2023-04-11T12:37:58Z | |
dc.date.created | 2022-05-13T13:35:36Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Moe, F. D. & Berg, H. (2022). Treating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines. Journal of Evaluation In Clinical Practice, 28(5), 703-923. | en_US |
dc.identifier.issn | 1365-2753 | |
dc.identifier.uri | https://hdl.handle.net/11250/3062410 | |
dc.description.abstract | Background:Substance use disorder (SUD) is often understood as a chronic illness. Aims: This paper investigates whether SUD is treated as a chronic illness. Method:To this aim, we have used World Health Organizations (WHO's) definitionof chronic illness to conduct a comparative analysis of SUD and type 2 diabetes(T2D), which is another chronic illness. Results:When analysing Norwegian treatment guidelines, we found that only theT2D guideline reflects the WHO's conceptualization of chronic illnesses. We arguethat this discrepancy implies that SUD is understood as a moral and legal problem,whileT2D is conceptualized as a somatic illness. We discuss how social, political andhistorical conditions of the possibility for understanding SUD are interwoven withnormative presumptions about the clinician, patient, treatment guidelines and drugpolicies in a way that may impede the development of continuing care. Conclusion:The paper concludes that the delivery of treatment services isinequitable as SUD is not treated as a chronic illness. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | John Wiley & Sons Ltd. | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Treating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | © 2022 The Author(s) | en_US |
dc.subject.nsi | VDP::Medisinske Fag: 700::Idrettsmedisinske fag: 850 | en_US |
dc.source.pagenumber | 703-923 | en_US |
dc.source.volume | 28 | en_US |
dc.source.journal | Journal of Evaluation In Clinical Practice | en_US |
dc.source.issue | 5 | en_US |
dc.identifier.doi | https://doi.org/10.1111/jep.13693 | |
dc.identifier.cristin | 2024388 | |
dc.description.localcode | Paid open access | en_US |
cristin.qualitycode | 1 | |